The average of price targets set by Wall Street analysts indicates a potential upside of 26.7% in Third Harmonic Bio, Inc. (THRD). While the effectiveness of this highly sought-after metric is ...

Investors need to pay close attention to Harmonic (HLIT) stock based on the movements in the options market lately.

Robot actuators must generate high torques, but at the same time be light and compact. The ideal application for the Harmonic ...

THB335 Phase 1 SAD/MAD clinical trial on track to deliver clinical results in 1Q’25 Strong financial position with cash and cash equivalents ...

The Harmonic Drive is a key part of countless robotic applications. Incredibly simple yet quite odd to watch, this gear system is extremely precise with an impressive torque-to-weight ratio, even if ...

Third Harmonic Bio, Inc. ( (THRD) ) has released its Q3 earnings. Here is a breakdown of the information Third Harmonic Bio, Inc. presented to ...

film soundtrack. In an Aug. 2024 feature, The Tennessean referred to "Woodland" as a "tight 10-track record that muses on loss and destruction, renewal and perseverance" with a "harmonic, thoughtful ...

SAN FRANCISCO, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Third Harmonic Bio, Inc. (Nasdaq: THRD), a clinical-stage biopharmaceutical company focused on advancing the next wave of medicine for dermal, ...

Q3 2024 Earnings Call Transcript October 29, 2024 Operator: Welcome to the Third Quarter 2024 Harmonic Earnings Conference ...

Harmonic Inc. reports strong Q3 results but faces concerns, leading to a cautious outlook. Click for more on HLIT Stock and its most recent earnings release.

Fintel reports that on October 29, 2024, Jefferies downgraded their outlook for Harmonic (NasdaqGS:HLIT) from Buy to Hold.

Harmonic (NASDAQ:HLIT – Get Free Report) was downgraded by Raymond James from a “strong-buy” rating to an “outperform” rating ...